HIV in 2012 A CME Debate Series

HIVin2012_WWW_FallBanner.jpg

HIV_in_2012_Fall_Register_Button.jpg

Content Links:

Program Overview
Target Audience
Commercial Support Acknowledgement
Learning Objectives 
Course Directors and Program Faculty
Program Moderators
Dates/Cities
Schedule for all Programs
Accreditation Statement/Credit Designation Statement
Disclosure of Conflicts of Interest 

Program Overview: 

The treatment of people with HIV infection is rapidly and constantly progressing as new research findings become available. With more than 25 approved antiretrovirals (ARVs) and 6 ARV classes, health care providers caring for HIV-positive patients have increasingly complex choices regarding ARV therapy for the management of treatment-naïve and treatment-experienced patients. While these choices provide health care providers and patients with important new options, they also lead to new challenges. For the health care provider treating HIV infection, it is very difficult to keep up with the rapidly increasing amount of new information that becomes available through journal articles, conference presentations, CME programs, and other sources. The availability and understanding of this constant stream of new research data and information are essential for providing the best possible ARV therapies and therapeutic strategies that are most likely to lead to successful and durable treatment in ARV-naïve and ARV-experienced patients.

As in 2011, this series will consist of 2-hour quarterly debate programs throughout the year in the following US locations: New York, NY; Miami, FL; Chicago, IL; Houston, TX; San Francisco, CA and Los Angeles, CA. Each meeting will feature a case-based debate format that will include important new data that have been presented or published throughout 2012. Program registrants/participants will have a chance to request topics live and via email, which will be considered for future scheduled debates in their city, along with the current topics already included in the program.

Back to Top

Target Audience: 

This activity is intended for physicians, physician assistants, advanced practice nurses, and other health care professionals involved in the treatment and management of patients with HIV infection.

Back to Top 

Commercial Support Acknowledgement: 

This activity is supported by an unrestricted educational grant by Gilead Sciences.  

Back to Top

Learning Objectives: 

Upon completion of the program, participants should be able to:

  • Initiate current ARV drug therapy for treatment-naïve patients with HIV based on guideline recommendations and current clinical research;

  • Incorporate appropriate therapeutic strategies in the management of treatment-experienced patients with HIV;

  • Use information regarding drug adverse events, drug pharmacokinetics and patient adherence to achieve ARV success and avoid morbidity and mortality;

  • Describe preventive care for the important opportunistic infections and co-morbidities that may increase the risk for morbidity and mortality in HIV positive patients;

  • Describe the importance of individualizing the care of each HIV-positive patient in clinical practice.

Back to Top

Course Directors and Program Faculty: 

Calvin J. Cohen, MD, MS
Research Director,
CRI New England
Clinical Instructor,
Harvard Medical School
Boston, Massachusetts
Ian Frank, MD
Associate Professor of Medicine,
Director, Antiretroviral Clinical Research
University of Pennsylvania
Philadelphia, Pennsylvania
Back to Top

Program Moderators: 


Roberto C. Arduino, MD
Professor of Medicine, UT Director of Research,
Thomas Street Clinic
The University of Texas-Houston
Houston, Texas

Lisa Capaldini, MD
Assistant Clinical Professor of Medicine,
University of California San Francisco School of Medicine
San Francisco, California

W. David Hardy, MD
Director,  Division of Infectious Diseases
Cedars-Sinai Medical Center
Associate Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Michael Sension, MD
Physician,
Comprehensive Care Center
Ft. Lauderdale, Florida

Renslow Sherer, MD
Professor of Medicine,
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Antonio A. Urbina, MD
Associate Medical Director,
Center for Comprehensive Care,
West Village Division
St. Luke’s Roosevelt Hospital
New York, New York

Dates/Cities - Fall: 


Thursday, November 8, 2012
Chicago, IL

Tuesday, November 27, 2012
Houston, TX

Thursday, November 29, 2012
New York, NY

  

  

  

Schedule for all Programs (Dinner Served):

6:00 - 6:30 PM    Registration/Meet Your Colleagues and Faculty
6:30 - 8:30 PM    Presentation

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Postgraduate Institute for Medicine and ViralEd, Inc.. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Back to Top

Credit Designation Statement: 

The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back to Top

Disclosure of Conflicts of Interest: 

The Postgraduate Institute for Medicine requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by the Postgraduate Institute for Medicine for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Back to Top

We look forward to bringing the highest-quality CME directly to you.

PIM-4C-logo_sml    VE logo 300px


Prepare to print

Share this page:

Get link code to this page     


Back to Top